{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:18:34Z","timestamp":1789499914424,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Large-cell neuroendocrine carcinoma (LCNEC) of the extrahepatic bile duct (EHBD) is an exceedingly rare malignancy with few documented cases, presenting significant diagnostic and therapeutic challenges. This case highlights the complexities in managing this aggressive tumor, the essential role of multidisciplinary collaboration, and the ongoing debates regarding the necessity of adjuvant therapy. It underscores the need for biomarker-guided strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 75-year-old male presented with a 2-week history of jaundice, pruritus, dark urine, nausea, and vomiting. Laboratory findings revealed severe cholestasis, with a total bilirubin level of 179.2 \u03bcmol\/L, and elevated CA19-9, measured at 457.36 U\/mL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Abdominal magnetic resonance imaging revealed a 1.4\u2009cm hilar bile duct mass with malignant characteristics. Postoperative histopathological analysis confirmed a 1.5\u2009cm tumor consisting of 90% poorly differentiated LCNEC, with a Ki-67 index of 80% and a PD-L1 combined positive score of 5. The tumor exhibited vascular invasion, neural infiltration, and metastasis to 2 lymph nodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>A multidisciplinary team (MDT) directed preoperative biliary drainage and performed a laparoscopic radical resection. Despite the presence of high-risk features, the patient declined adjuvant chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Six months post-surgery, an enhanced abdominal magnetic resonance imaging scan revealed intrahepatic metastases. Consequently, the patient commenced chemotherapy with a combination of cisplatin and etoposide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case underscores the aggressive nature of LCNEC of the EHBD and the crucial role of MDT-driven surgical intervention. The rapid recurrence suggests the necessity for postoperative adjuvant therapy; however, standard treatment protocols are lacking due to insufficient evidence from evidence-based medicine, highlighting the need for biomarker-driven strategies. The rarity of these tumors renders standardized management elusive, necessitating global collaboration to refine diagnostic and therapeutic frameworks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045332","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:02:08Z","timestamp":1762210928000},"page":"e45332","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic challenges and therapeutic strategies for large-cell neuroendocrine carcinoma of extrahepatic bile ducts: A rare case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Bolun","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9667-4761","authenticated-orcid":false,"given":"Xiangnan","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","article-title":"JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.","volume":"56","author":"Ito","year":"2021","journal-title":"J Gastroenterol"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"e939239","DOI":"10.12659\/AJCR.939239","article-title":"Neuroendocrine carcinoma of the extrahepatic bile ducts: a case report.","volume":"24","author":"Jevdokimov","year":"2023","journal-title":"Am J Case Rep"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.3748\/wjg.v19.i28.4616","article-title":"Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review.","volume":"19","author":"Sasatomi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4143\/crt.2012.44.3.157","article-title":"Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study.","volume":"44","author":"Cho","year":"2012","journal-title":"Cancer Res Treat"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MCG.0b013e3181d7a6d4","article-title":"Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy.","volume":"44","author":"Eltawil","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms.","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s12328-024-01982-3","article-title":"Mixed neuroendocrine-non-neuroendocrine neoplasm of the bile duct with long-term prognosis after neoadjuvant chemotherapy.","volume":"17","author":"Nakamura","year":"2024","journal-title":"Clin J Gastroenterol"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"e39848","DOI":"10.1097\/MD.0000000000039848","article-title":"Large-cell neuroendocrine carcinoma of the bile duct: case report of surgical treatment and adjuvant chemotherapy of 2 cases.","volume":"103","author":"Seo","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"e13249","DOI":"10.1111\/jne.13249","article-title":"European neuroendocrine tumor society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.","volume":"35","author":"Sorbye","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1097\/RLU.0000000000000729","article-title":"SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approach.","volume":"40","author":"Werner","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000338794","article-title":"Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma.","volume":"96","author":"Terashima","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.asjsur.2024.08.036","article-title":"A large cell neuroendocrine carcinoma in the extrahepatic bile duct: a case report and literature review.","volume":"48","author":"Li","year":"2024","journal-title":"Asian J Surg"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4166\/kjg.2018.72.6.318","article-title":"Large cell neuroendocrine carcinoma of the extrahepatic bile duct.","volume":"72","author":"Park","year":"2018","journal-title":"Korean J Gastroenterol"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00534-009-0051-4","article-title":"Small-cell carcinoma in the common bile duct treated with multidisciplinary management.","volume":"16","author":"Okamura","year":"2009","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3904\/kjim.2017.188","article-title":"Primary large cell neuroendocrine carcinoma of the common hepatic duct mimicking a Klatskin tumor.","volume":"34","author":"Koo","year":"2019","journal-title":"Korean J Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:01:20Z","timestamp":1789498880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":15,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045332","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-05-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}